Last edition
News about "AK0406 Phase 2 clinical trial"
ArkBio Wins FDA Clearance for AK0406 Phase 2 Trial
ArkBio has received US FDA clearance for its phase 2 AK0406 trial, evaluating influenza prevention in adults during an influenza season.
AK0406 Phase 2 Clinical Trial | 14/10/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members